Literature DB >> 34893769

The race to make vaccines for a dangerous respiratory virus.

Kendall Powell.   

Abstract

Entities:  

Keywords:  Industry; Vaccines; Virology

Mesh:

Substances:

Year:  2021        PMID: 34893769     DOI: 10.1038/d41586-021-03704-y

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  4 in total

1.  Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus.

Authors:  Jason S McLellan; Man Chen; M Gordon Joyce; Mallika Sastry; Guillaume B E Stewart-Jones; Yongping Yang; Baoshan Zhang; Lei Chen; Sanjay Srivatsan; Anqi Zheng; Tongqing Zhou; Kevin W Graepel; Azad Kumar; Syed Moin; Jeffrey C Boyington; Gwo-Yu Chuang; Cinque Soto; Ulrich Baxa; Arjen Q Bakker; Hergen Spits; Tim Beaumont; Zizheng Zheng; Ningshao Xia; Sung-Youl Ko; John-Paul Todd; Srinivas Rao; Barney S Graham; Peter D Kwong
Journal:  Science       Date:  2013-11-01       Impact factor: 47.728

2.  Delayed Seasonal RSV Surge Observed During the COVID-19 Pandemic.

Authors:  Rabia Agha; Jeffrey R Avner
Journal:  Pediatrics       Date:  2021-06-09       Impact factor: 7.124

3.  Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis.

Authors:  Shanshan Zhang; Lily Zainal Akmar; Freddie Bailey; Barbara A Rath; Maren Alchikh; Brunhilde Schweiger; Marilla G Lucero; Leilani T Nillos; Moe H Kyaw; Alexia Kieffer; Sabine Tong; Harry Campbell; Philippe Beutels; Harish Nair
Journal:  J Infect Dis       Date:  2020-10-07       Impact factor: 5.226

4.  Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.

Authors:  Daniel Wrapp; Nianshuang Wang; Kizzmekia S Corbett; Jory A Goldsmith; Ching-Lin Hsieh; Olubukola Abiona; Barney S Graham; Jason S McLellan
Journal:  Science       Date:  2020-02-19       Impact factor: 47.728

  4 in total
  3 in total

Review 1.  Challenges in Maximizing Impacts of Preventive Strategies against Respiratory Syncytial Virus (RSV) Disease in Young Children.

Authors:  Zhe Zheng
Journal:  Yale J Biol Med       Date:  2022-06-30

Review 2.  Protein and Peptide Substances in the Treatment of Respiratory Syncytial Infection: Current State.

Authors:  Anna A Shtro; Galina D Petukhova; Aleksandra S Romanova
Journal:  Molecules       Date:  2022-03-31       Impact factor: 4.411

3.  Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity.

Authors:  Clara Maier; Jana Fuchs; Pascal Irrgang; Michael Hermann Wißing; Jasmin Beyerlein; Matthias Tenbusch; Dennis Lapuente
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.